Skip to main content
PureTech Health plc logo

PureTech Health plc — Investor Relations & Filings

Ticker · PRTC ISIN · GB00BPVG5C82 LEI · 213800LVPDNO2Z9T9I39 IL Manufacturing
Open in API
Filings indexed 1,321 across all filing types
Latest filing 2020-03-10 Report Publication Anno…
Country GB United Kingdom
Listing IL PRTC

About PureTech Health plc

https://puretechhealth.com/

PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.

Recent filings

Filing Released Lang Actions
Notice of Results
Report Publication Announcement Classification · 98% confidence The document is identified by the 'RNS Number' header and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content announces the future date for the release of financial results ('plans to announce its financial results for the year ended 31 December 2019 on Thursday, 9 April 2020') and mentions an accompanying presentation/conference call. Since this document is an announcement about the timing of a future report release, rather than the report itself (which would likely be an ER or 10-K), it fits the definition of a Report Publication Announcement (RPA). The document length (4137 chars) is also consistent with a brief announcement rather than a full financial report.
2020-03-10 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is very short (1501 characters) and contains an 'RNS Number' and mentions 'RNS, the news service of the London Stock Exchange'. The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a specific, immediate operational announcement rather than a comprehensive financial report (like 10-K or IR) or a standard corporate action (like DIV or CAP). Since it is a general regulatory announcement disseminated via the RNS system that doesn't fit into the more specific categories (like DIRS, MANG, or DIV), the most appropriate classification is the general regulatory fallback category.
2020-03-09 English
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document is very short (1484 characters) and contains an 'RNS Number' and mentions 'RNS, the news service of the London Stock Exchange'. The content itself is a specific, brief announcement regarding a 'Price Monitoring Extension' for an auction call period. This type of short, immediate regulatory update that doesn't fit into specific financial reporting categories (like 10-K, ER, or IR) is best classified as a general Regulatory Filing, which corresponds to the RNS code. It is not an announcement of a report (RPA) but a direct regulatory notice.
2020-03-09 English
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document is very short (1484 characters) and contains an 'RNS Number' header, indicating it is a regulatory news service announcement from the London Stock Exchange. The content specifically discusses a 'Price Monitoring Extension' and an 'auction call period extension' for a security. This type of operational market announcement, which does not fit into specific financial reporting categories (like 10-K, ER, or IR), is best classified under the general regulatory announcement category, RNS, as per the definitions and the presence of the RNS identifier.
2020-03-06 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is very short (1501 characters) and contains an RNS Number (2001F) and is explicitly stated to be provided by RNS, the news service of the London Stock Exchange. The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a specific, non-standard regulatory announcement. Since it is a direct announcement disseminated via the RNS system and does not fit the definitions for financial reports (10-K, IR, ER), management changes (MANG), or specific shareholder actions (DIV, DVA), the most appropriate classification is the general regulatory announcement category, RNS.
2020-03-05 English
Second Price Monitoring Extn
Share Issue/Capital Change Classification · 99% confidence The document text contains an 'RNS Number' and explicitly states that the information is provided by 'RNS, the news service of the London Stock Exchange.' The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a type of market announcement. Since this is a general regulatory announcement that doesn't fit the specific categories like DIV, ER, or 10-K, the most appropriate classification is the general Regulatory Filings category (RNS). The document length is short (1501 chars), but it is the announcement itself, not an announcement *about* another report, so RNS is preferred over RPA.
2020-03-03 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.